Browse medicines, page 10 of 10
Some records contain detailed evidence; others currently contain only basic identity and regulatory information. Reviewed conclusions appear only when they are available for a specific use and group of people.
Showing 541–546 of 546 records
Tremelimumab-Actl (Imjudo)
Protein medicineApproved in the United States (FDA)Expanded recordVeligrotug (Lumvoa)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Thyroid eye disease regardless of thyroid eye disease activity or duration
Rituximab-Arrx (Riabni)
Protein medicineApproved in the United States (FDA)Expanded recordSotatercept-Csrk (Winrevair)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Pulmonary arterial hypertension (PAH, Group 1 pulmonary hypertension) to improve exercise capacity and World Health Organization
Thyrotropin alfa (Thyrogen)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
THYROGEN ® is a thyroid stimulating hormone indicated for: Adjunctive Diagnostic Tool for Well-Differentiated Thyroid Cancer: Use as an adjunctive diagnostic tool for serum thyroglobulin (Tg) testing with or without radioiodine imaging in the follow-up of patients with well-differentiated thyroid cancer who have previously undergone thyroidectomy. ( 1.1 ) Limitations of Use : THYROGEN-stimulated Tg levels are generally lower than, and do not correlate with Tg levels after thyroid hormone withdrawal.
Toripalimab-Tpzi (Loqtorzi)
Protein medicineApproved in the United States (FDA)Expanded record